Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Isoproterenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 7/20 | 0.97 |
| ▸ | ADRB1 known ✓ | P08588 | 5/20 | 0.97 |
| ▸ | ADRB3 known ✓ | P13945 | 5/20 | 0.97 |
| ▸ | MAPT | P10636 | 7/20 | 0.97 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.97 |
| ▸ | TSHR | P16473 | 5/20 | 0.97 |
| ▸ | MEN1 | O00255 | 5/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.97 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.97 |
| ▸ | MTOR | P42345 | 3/20 | 0.97 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.97 |
| ▸ | LMNA | P02545 | 2/20 | 0.97 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.97 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.97 |
| ▸ | DRD2 | P14416 | 2/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoproterenol SCHEMBL4165 | 0.98 | MAPT (1.00) | MAPTADRB2TDP1KDM4EADRB1 | |
| Isoproterenol SCHEMBL4166 | 0.98 | MAPT (1.00) | MAPTADRB2TDP1KDM4EADRB1 | |
| Levisoprenaline SCHEMBL29620666 | 0.98 | MAPT (1.00) | MAPTADRB2TDP1KDM4EADRB1 | |
| Levisoprenaline SCHEMBL250806 | 0.98 | MAPT (1.00) | MAPTADRB2TDP1KDM4EADRB1 | |
| Isoproterenol SCHEMBL3253794 | 0.98 | MAPT (1.00) | MAPTADRB2TDP1KDM4EADRB1 | |
| Isoproterenol SCHEMBL29386243 | 0.98 | MAPT (1.00) | MAPTADRB2TDP1KDM4EADRB1 | |
| Isoproterenol SCHEMBL29519146 | 0.98 | MAPT (1.00) | MAPTADRB2TDP1KDM4EADRB1 | |
| Levisoprenaline SCHEMBL4745572 | 0.97 | MAPT (1.00) | MAPTADRB2TDP1KDM4EADRB1 | |
| Isoproterenol SCHEMBL6151626 | 0.97 | MAPT (0.97) | MAPTADRB2TDP1KDM4EADRB1 | |
| Isoproterenol SCHEMBL7627 | 0.97 | MAPT (1.00) | MAPTADRB2TDP1KDM4EADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170153225-A1 | A METHOD OF SCREENING FOR A COMPOUND CAPABLE OF STIMULATING GLUCOSE TRANSPORT INTO BROWN AND/OR BRITE ADIPOCYTES OF A MAMMAL, A KIT FOR USE IN SUCH A METHOD | ATROGI AB (SE) | 2017-06-01 | — | — | US | disclosed |
| WO-2016004995-A1 | A METHOD OF SCREENING FOR A COMPOUND CAPABLE OF STIMULATING GLUCOSE TRANSPORT INTO BROWN AND/OR BRITE ADIPOCYTES OF A MAMMAL, A KIT FOR USE IN SUCH A METHOD | ATROGI AB (SE) | 2016-01-14 | — | — | WO | disclosed |
| US-20110275563-A1 | Use of CTGF as a Cardioprotectant | UNIVERSITY OF OSLO (NO) | 2011-11-10 | — | — | US | disclosed |
| EP-2344181-A1 | USE OF CTGF AS A CARDIOPROTECTANT | Universitetet I Oslo (NO) | 2011-07-20 | — | — | EP | disclosed |
| WO-2010032007-A1 | USE OF CTGF AS A CARDIOPROTECTANT | UNIVERSITETET I OSLO (NO) | 2010-03-25 | — | — | WO | disclosed |
| US-7615610-B2 | Modified trafficking patterns for arrestin and G-protein-coupled receptors via arrestin-ubiquitin chimera | DUKE UNIVERSITY (US) | 2009-11-10 | — | — | US | disclosed |
| US-20060263828-A1 | Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-11-23 | — | — | US | disclosed |
| EP-1590438-A2 | MODIFIED TRAFFICKING PATTERNS FOR ARRESTIN AND G-PROTEIN-COUPLED RECEPTORS VIA ARRESTIN-UBIQUITIN CHIMERA | DUKE UNIVERSITY (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-1539177-A2 | COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE | Crackower, Michael A. (US) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004067717-A2 | MODIFIED TRAFFICKING PATTERNS FOR ARRESTIN AND G-PROTEIN-COUPLED RECEPTORS VIA ARRESTIN-UBIQUITIN CHIMERA | DUKE UNIVERSITY (US) | 2004-08-12 | — | — | WO | disclosed |
| WO-2004026285-A2 | COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE | AMGEN CANADA INC. (CA) | 2004-04-01 | — | — | WO | disclosed |